Coral today announced a $12.5M funding round led by Lightspeed and Z47. A strong validation signal from investors known for backing category-defining enterprise platforms. This positions the company at the forefront of a new wave of AI-driven healthcare admin transformation.
In under a year, Coral has already achieved:
- 99.7% accuracy on handwritten faxes, PA forms, and insurance cards.
- Complete patient intakes in under 5 minutes, even for complex specialty cases.
- Customers paying full contracts upfront, signaling immediate ROI confidence.
- Deployment across DME, now rapidly scaling into infusion and radiology.
Ever wondered why, despite digital transformation, your front desk still runs on paper and fax?
Healthcare has spent a decade digitizing records, yet its most critical workflows still run on fax machines. This disconnect is where modern AI is finally finding its foothold.
Coral’s approach is simple but disruptive. Instead of forcing change inside the EHR, it automates everything around it, converting unstructured inputs into clean, usable data in minutes.
Across infusion centers, Durable Medical Equipment (DME) suppliers, and radiology groups, intake inefficiencies are quietly adding hundreds of dollars per patient episode in rework, delays, and lost revenue.
About Coral and its Top-Tier Investors
Coral
Coral is a healthcare automation platform built for specialty providers. By combining intelligent document processing, agentic workflows, and voice automation,
It integrates with existing EHR systems, fax lines, and payer portals to automate administrative workflows from patient intake and prior authorization to billing, compliance, and patient outreach.
Coral reduces human error, accelerates care delivery, and frees up healthcare staff to focus on the work that requires judgment and empathy.
Lightspeed
Lightspeed is a global multi-stage venture capital firm focused on accelerating disruptive innovations and trends in the Enterprise, Consumer, Health, and Fintech sectors.
Over the past two decades, the Lightspeed team has backed hundreds of entrepreneurs and helped build more than 500 companies globally, including:
- Affirm
- Acceldata
- Carta
- Cato Network
- Darwinbox
- Faire
- Innovaccer
- Guardant Health
- Mulesoft
- Navan
- Netskope
- Nutanix
- Physics Wallah
- Razorpay
- Rubrik
Lightspeed and its global team currently manage $30bn+ in AUM across the Lightspeed platform, with investment professionals and advisors in the U.S., Europe, India, Israel, and Southeast Asia.
Z47
Founded in 2006, Z47 is an investment Firm with more than 150 investments to date and an AUM of over $3.5 billion. Guided by a ‘founders first’ philosophy, Z47 is committed to backing and prioritising missionary founders over markets.
Z47’s focus sectors include Enterprise AI, Financial Services, Consumer, B2B, and Advanced Manufacturing, amongst others. We are proud partners to several Enterprise AI companies; select ones include AtomicWork, Krutrim, MoEngage, Rocketlane, and Toddle.
Other select investments include Dailyhunt, Five Star Business Finance, OfBusiness, Ola, Ola Electric, and Razorpay.
How This Translates into Real Market Advantage
1. Capital to Speed and Scale
Recent data from PR Newswire highlights Coral’s rapid operational and commercial momentum. In its latest announcement, the company reported processing over 500,000 patient workflows per month, while achieving more than 8x revenue growth in just seven months.
This is standard, but essential. Most healthcare startups fail because they can’t scale deployment fast enough.
2. Credibility to Faster Enterprise Adoption
In healthcare:
- Buyers are risk-averse.
- Sales cycles are long.
- Trust accelerates procurement decisions.
This likely explains why Coral is seeing customers pay up front, which is rare in health IT.
3. Strategic Guidance to Better Positioning
Top-tier investors don’t just fund. They help shape:
- Go-to-market strategy.
- Enterprise sales motion.
- Expansion into high-value segments.
In Coral’s case, the shift from DME to infusion to radiology shows intentional vertical expansion, not random growth.
4. Network Access to Enterprise Entry Points
Investors open doors to:
- Large provider networks.
- Strategic partners.
- Payer relationships.
That can significantly shorten the time it takes to land major healthcare clients.
How are top vendors turning investor networks into enterprise deals?
Read more on Cyber Technology Insights
5. Product Direction to ROI Focus
Modern investors, especially in 2026, are pushing startups toward:
- Measurable ROI.
- Revenue impact (not just efficiency claims).
- Fast deployment.
That aligns directly with Coral’s positioning:
- <5-minute intake.
- 99.7% accuracy.
- Denial reduction focus.
Current Market Trends in Healthcare Admin Automation
The majority of inefficiencies are not buried deep within complex systems. They sit at the very front of the workflow, where unstructured data first enters the organization.
Against this backdrop, several key trends are defining how healthcare leaders are approaching administrative automation today:
1. The trillion-dollar administrative burden is finally being quantified
US healthcare administrative costs continue to hover near $1 trillion annually, with a disproportionate share concentrated in specialty workflows that depend on:
- Fax-based referrals.
- Manual prior authorization (PA) processes.
- Fragmented EHR ecosystems.
Benchmarks from MGMA and HFMA consistently show:
- 30% of staff time is spent on administrative work.
- 15% average denial rates, with many tied to intake errors or incomplete documentation.
For specialty providers, these numbers are often worse. Infusion centers and DME suppliers operate under heavier documentation requirements, making them especially vulnerable to intake inefficiencies.
2. Post-CMS rule changes have triggered a PA explosion
Recent CMS policy shifts aimed at standardizing prior authorizations have had a paradoxical effect. While digitization is encouraged, the volume and complexity of PAs have surged, especially for high-cost therapies and equipment.
Result:
- Intake teams are overwhelmed.
- Turnaround times are increasing.
- Revenue cycles are extending.
This is particularly acute in:
- Infusion therapy, where delays directly impact patient outcomes.
- DME, where eligibility verification errors stall fulfillment.
- Radiology, where incomplete referrals lead to scheduling gaps.
3. AI in healthcare is shifting from experimentation to ROI pressure
In 2026, the conversation has changed. AI is no longer a pilot initiative. It is a budget line item expected to deliver measurable returns.
Current adoption dynamics:
- 40% of providers are piloting AI solutions.
- <20% successfully scale deployments.
The primary failure point is not model performance. It is integration friction.
Most AI tools fail because they require:
- Workflow redesign.
- EHR replacement or heavy customization.
- Staff retraining.
This is why “fax-proof” solutions are gaining traction. They work within existing infrastructure, not against it.
The Data That Proves It
Coral’s early traction is not theoretical. It is operational, measurable, and tied directly to revenue outcomes.
Core Performance Metrics
- 98.7% document accuracy
Handles handwritten faxes, PA forms, and insurance cards with near-perfect extraction.
- End-to-end intake time reduced by 81%
From raw fax to structured, EHR-ready data.
- Full contract payments upfront
Indicates immediate ROI realization by customers.
- Record-breaking growth target by year-end
Driven by expansion into infusion and radiology.
Operational Impact (Modeled)
Before Coral:
- Intake time: 20–45 minutes per patient.
- Error rate: 5–10%.
- Denial risk tied to intake: High.
- Staff workload: Overextended.
After Coral:
- Intake time: <5 minutes.
- Error rate: <0.3%.
- Denial risk: Significantly reduced.
- Staff redeployment: Higher-value tasks.
Specialty-Specific Gains
Administrative inefficiencies do not impact all healthcare segments equally. Specialty providers. particularly in infusion, DME, and radiology.
Infusion Centers
- Faster patient onboarding.
- Reduced therapy delays.
- Improved chair utilization.
DME Suppliers
- Cleaner eligibility verification.
- Faster order fulfillment.
- Reduced rework cycles.
Radiology Practices
- Complete referral packets upfront.
- Fewer scheduling disruptions.
- Higher scan volume throughput.
Vendor Analysis of Coral
As healthcare AI adoption matures, vendor evaluation is no longer driven by feature sets alone. Buyers are prioritizing time-to-value, integration friction, and measurable impact on revenue cycle performance.
For specialty providers in particular, the bar is higher. Any solution that disrupts existing workflows risks slowing operations rather than improving them.
Strengths: Precision, Speed, and Zero-Disruption Integration
Coral’s core advantage is not just accuracy. It is accuracy within legacy workflows.
1. Best-in-class document intelligence
- Handles low-quality faxes and handwritten inputs.
- Extracts structured data with 99.7% accuracy.
- Reduces downstream correction cycles.
2. No rip-and-replace requirement
- Works on top of existing fax and EHR systems.
- Eliminates integration bottlenecks.
- Enables rapid deployment.
3. Built for specialty complexity
- Designed around real-world intake chaos.
- Handles multi-document, multi-step workflows.
- Adapts to payer-specific requirements.
Competitive Positioning
Vs. Generic RPA platforms (e.g., UiPath):
- RPA struggles with unstructured inputs like handwritten faxes.
- Requires heavy rule-based configuration.
- Breaks under variability.
Coral replaces brittle automation with AI-native document understanding.
Vs. EHR-native add-ons:
- Limited to structured data inputs.
- Often require workflow changes.
- Slow to deploy across departments.
Coral operates outside the EHR constraint layer, feeding it clean data instead.
Founder Insight and Customer Obsession
The founding team, Ajay Shrihari and Aniket Mohanty, built Coral from firsthand exposure to administrative breakdowns in patient intake workflows.
This shows up in:
- Product design aligned with real operator pain.
- Rapid iteration based on customer feedback.
- High willingness among customers to pay upfront.
Investor Validation
“In the durable medical equipment sector, the manual order intake process has been historically very cumbersome and difficult to optimize. At DASCO, we partnered with Coral because their AI-driven software will address this by streamlining intake with enhanced accuracy and speed, reducing turnaround times from hours/days to mere minutes,” said Michael Gorman, President at DASCO Home Medical Equipment.
Rohil Bagga, Investor at Lightspeed, added: “Healthcare is one of the hardest environments to automate, given legacy systems and fragmented workflows, yet Coral is delivering real outcomes at scale. Their product is already being used by some of the largest customers in the U.S. to dramatically reduce patient intake times and first-pass denials. At Lightspeed, we’ve had the privilege of being part of Coral’s journey since day one, and we’re excited to continue supporting the team as they transform the healthcare industry.”
Ashwin KP, Investor at Z47, commented: “US healthcare admin carries over a trillion dollars in overhead each year, yet the back-office teams doing this work have been chronically underserved by technology. Our thesis is that the most compelling AI opportunities lie in workflow-heavy, tech-underserved categories that demand deep vertical expertise to crack.
“Ajay and Aniket are exceptionally customer-obsessed founders who embedded themselves with these teams, understood their pain at a granular level, and built a product their customers can’t live without. The rapid growth and the caliber of customers they’ve won in a short time only reinforced our conviction. We’re privileged to partner with them,” he added.
“Legacy automation vendors have struggled in healthcare because they have tried to rebuild systems from the ground up,” said Ajay Shrihari, co-founder of Coral. “Our approach is different. We accept the complexity of healthcare as it exists today and automate within current processes, delivering value on day one without our customers having to upend their entire infrastructure.”
Risks and Mitigations
As healthcare organizations move from pilot programs to enterprise-wide AI adoption, risk evaluation becomes a critical part of vendor selection.
1. Scalability risk
- Rapid growth across specialties can strain infrastructure.
- Mitigation: $12.5M funding to expand engineering and deployment capacity.
2. Integration edge cases
- Highly customized provider workflows may introduce variability.
- Mitigation: Flexible AI models trained on diverse document sets.
3. Competitive pressure
- Large incumbents may attempt to replicate capabilities.
- Mitigation: First-mover advantage in fax-native AI and deep specialty focus.
Product Roadmap: Beyond Intake Automation
On the product side, the company recently shipped AI-powered voice and text workflows, automating follow-ups with payers, patients, and referral sources that would previously require a staff member to pick up the phone. The next phase goes further.
Coral is building an AI workflow builder that lets providers design and deploy their own administrative workflows without raising an IT ticket, adapting Coral to the way their operations actually run rather than the other way around.
Alongside that, Coral is developing what it describes as a co-pilot layer for the business: a way to surface intelligence from the data it already processes.
The ambition is that a practice manager can ask Coral what is slowing their operation down and get a specific, actionable answer, not a report to interpret, but a clear next step.
The system is not going to simplify itself. Coral’s answer is that administration is a workflow problem, not a staffing one. Across DME, infusion, and specialty pharmacy, that answer is proving out. The fax queue gets shorter. Staff get to spend their time on patients.
Coral is not stopping at document processing. The roadmap includes:
1. AI Co-pilot for intake teams
- Real-time assistance during patient onboarding.
- Intelligent error detection and correction.
2. Voice-enabled workflows
- Capture and structure verbal inputs.
- Extend automation beyond fax.
3. AI Builder Platform
- Custom workflow automation for providers.
- Tailored to specialty-specific needs.
The long-term vision is clear. Not just automating intake, but redefining how administrative workflows operate across healthcare.
The Front Door of Healthcare Is Finally Being Rebuilt
The next phase of healthcare transformation will not be won inside the EHR. It will be won at the point where data first enters the system.
For decades, specialty providers have been forced to operate with a fundamental disconnect. Highly advanced clinical care layered on top of intake processes that rely on faxes, manual entry, and fragmented workflows.
The result has been predictable. Slower patient access, higher denial rates, and mounting administrative costs that directly erode margins.
What Coral demonstrates is a shift in where and how automation delivers value. Not by overhauling core systems, but by eliminating the inefficiencies before they have a chance to propagate downstream.
When intake is clean, fast, and accurate, everything that follows. From authorization to reimbursement, becomes more predictable and scalable.
FAQs
1. How can specialty providers reduce prior authorization delays in 2026?
By automating intake and documentation workflows before submission. AI-driven extraction from faxes and forms ensures complete, accurate data, reducing rework and accelerating approvals.
2. What is the fastest way to improve patient intake efficiency in infusion and DME?
Implementing AI that converts unstructured inputs like faxes into structured, EHR-ready data in minutes. This cuts intake time drastically without requiring system replacement.
3. Why do healthcare AI pilots fail to scale across organizations?
Most fail due to integration complexity and workflow disruption. Solutions that layer onto existing systems and require minimal change are far more likely to scale successfully.
4. How does poor intake data impact denial rates and revenue cycles?
Incomplete or inaccurate intake data leads to submission errors, increasing first-pass denial, and delaying reimbursements. Clean intake data directly improves revenue predictability.
5. What should CIOs look for when evaluating healthcare admin automation vendors?
Focus on accuracy with unstructured data, ease of integration with legacy systems, measurable ROI within weeks, and the ability to scale across departments without workflow disruption.
